Tag: obesity
-

Low-Density Suburbs: A Hidden Driver of Obesity and Inequality, New Research Finds
Overview: What the study reveals about low-density suburbs A new research wave is drawing attention to how the design of our neighborhoods might contribute to widening health and economic gaps. The study links low-density, car-oriented suburbs with higher obesity rates and more pronounced social inequality. Researchers argue that when residential areas sprawl with few sidewalks,…
-

Low-density suburbs linked to obesity and inequality, research reveals
New findings spotlight how suburb design affects health A growing body of research is drawing a direct line between the low-density layouts of many modern suburbs and two persistent public health challenges: rising obesity and widening inequality. While individual choices matter, planners and health experts say the built environment can either facilitate healthy habits or…
-

Wegovy Moves Closer to PBS Listing for Adults with Obesity and Heart Disease
What is Wegovy and why the PBS listing matters Semaglutide, marketed as Wegovy, is a prescription medication designed to help adults with obesity lose weight and improve related health risks. The latest development from the Pharmaceutical Benefits Advisory Committee (PBAC) signals a significant step toward adding Wegovy to the Pharmaceutical Benefits Scheme (PBS) for people…
-

Wegovy Advances to PBS Listing: Semaglutide for Obesity and Heart Disease
Wegovy Moves Closer to PBS Listing Semaglutide, sold under the brand Wegovy, is nearing a pivotal milestone in Australia’s healthcare system. After preliminary recommendations from the Pharmaceutical Benefits Advisory Committee (PBAC), Wegovy could soon be available on the Pharmaceutical Benefits Scheme (PBS) for adults with established cardiovascular disease who also have obesity. This potential PBS…
-

Wegovy Moves Closer to PBS Listing for Australians with Obesity and Heart Risk
What’s happening with Wegovy and the PBS The anti-obesity drug Wegovy, whose active ingredient is semaglutide, has taken a significant step toward being added to Australia’s Pharmaceutical Benefits Scheme (PBS). The move signals a potential change in how adults living with obesity and established cardiovascular disease could access a proven therapy at a reduced price,…
-

Tackling Unsustainable Food Systems for Health and Climate Gains
Why unsustainable food systems matter for health and the climate The latest synthesis in Frontiers in Science makes a compelling case that our changing food environment is more than a nutrition issue—it’s a planetary health crisis. The review highlights how unsustainable food systems contribute to rising obesity rates while exacerbating environmental harms such as greenhouse…
-

Tackling Unsustainable Food Systems for Health and Climate Benefits
Introduction: The double-edged challenge of our food environment Recent evidence summarized in a major Frontiers in Science review highlights a critical reality: our changing food environment is fueling both rising obesity and mounting environmental harms. Tackling unsustainable food systems is not just a health issue; it is a climate action imperative. By realigning what, how,…



